Two case reports of fulminant giant cell myocarditis treated with rabbit anti-thymocyte globulin.
Colin Bartz-OvermanSarah LiBalaram PuligandlaNalini ColacoJohannes SteinerLuke MashaPublished in: European heart journal. Case reports (2024)
In aggregate, these cases are typical of GCM. They add to growing observational data that upfront rabbit anti-thymocyte globulin may reduce morbidity and mortality in GCM, including potentially preventing the need for complex interventions like orthotopic heart transplantation.